DrugPatentWatch Database Preview
Drugs in Development Information for Dimethicone
Email this page to a colleague
» See Plans and PricingWhat is the development status for investigational drug Dimethicone?
Dimethicone is an investigational drug.
There have been 5 clinical trials for Dimethicone.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2009.
The most common disease conditions in clinical trials are Radiodermatitis, Dermatitis, and Psoriasis. The leading clinical trial sponsors are University of British Columbia, G. Pohl-Boskamp GmbH & Co. KG, and Universitätsklinikum Hamburg-Eppendorf.
Summary for Dimethicone
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 2,187 |
| WIPO Patent Applications | 1,264 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2009-05-01) |
| Vendors | 49 |
Recent Clinical Trials for Dimethicone
| Title | Sponsor | Phase |
|---|---|---|
| Topical Menthol +/- Mannitol for Painful Diabetic Peripheral Neuropathy | University of British Columbia | Phase 1/Phase 2 |
| Topical Use of Difinsa53™ to Prevent Radiation Dermatitis | Poudre Valley Health System | Phase 1/Phase 2 |
| Topical Use of Difinsa53™ to Prevent Radiation Dermatitis | ProTechSure Scientific, Inc. | Phase 1/Phase 2 |
Clinical Trial Summary for Dimethicone
Top disease conditions for Dimethicone
Top clinical trial sponsors for Dimethicone
US Patents for Dimethicone
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
